Patterns of Care (POC) Quality of Care Dx Yr 2011

国家癌症研究所(NCI)建立了监测、流行病学和最终结果(SEER)计划，以定期收集和报告基于人群的癌症发病率和生存数据。它是NCI监测活动的核心组成部分，提供用于规划癌症控制和研究计划的信息，并用于评估此类计划对癌症发病率的影响。 SEER计划于1972年启动，以响应国家癌症计划的要求，评估美国癌症负担的大小，并确定与癌症风险和/或患者生存相关的因素。预见性护理模式研究描述、描述和比较美国不同地理区域为癌症提供的实践模式和治疗方法。先知护理模式研究是为了满足国会指令(根据公法100-607，SEC.413(A)(2)(C)(1988年11月4日通过)提交给国家癌症研究所，以“评估将最先进的癌症治疗纳入临床实践的情况以及癌症患者接受这种治疗的程度，并将评估的结果纳入两年一次的报告”。为了选择符合这一指令的癌症，癌症控制和人口科学部一直与癌症治疗部密切合作。今年的护理模式(POC)研究将调查2010年诊断的早期乳腺癌、II期和III期结直肠癌和非小细胞肺癌的最新疗法。

The Surveillance, Epidemiology, and End Results (SEER) Program was established by the National Cancer Institute (NCI) to collect and report periodically on population-based cancer incidence and survival data. It is a core component of the NCI's surveillance activities which provide information used for planning cancer control and research programs, and for evaluating the impact of such programs on cancer rates. The SEER Program was initiated in 1972 in response to requirements of the National Cancer Program for assessing the magnitude of the cancer burden in the United States, and for identifying factors related to cancer risk and/or patient survival. SEER Patterns of Care Studies describe, characterize, and compare practice patterns and treatments provided for cancer in different geographic areas of the United States. SEER Patterns of Care Studies are conducted to satisfy a Congressional directive (under Public Law 100-607, Sec. 413 (a)(2)(C) adopted November 4, 1988) to the National Cancer Institute to ¿assess the incorporation of state-of-the-art cancer treatments into clinical practice and the extent to which cancer patients receive such treatments and include the results of such assessment in the biennial reports¿¿. To select the cancers to satisfy this directive, the Division of Cancer Control and Population Sciences has been working closely with the Division of Cancer Treatment. This year's Pattern's of Care (POC) Study will investigate state-of-the-art therapies for early stage breast, Stage II and III colorectal, non-small cell lung cancer diagnosed in 2010.